These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11204837)

  • 21. [Clinical aspects of prenatal prevention of rhesus incompatibility].
    Maas DH
    Beitr Infusionsther; 1992; 30():425-30. PubMed ID: 1284752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 23. [Epidemiology of anti-D allo-immunization during pregnancy].
    Branger B; Winer N
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemosorption in the prevention of severe forms of hemolytic disease of the newborn in rhesus sensitization].
    Konopliannikov AG; Saĭkina EA; Goriushina NB; Panina OB
    Akush Ginekol (Mosk); 1993; (6):31-3. PubMed ID: 8311153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosing hemolytic disease of the newborn.
    Brantley TA
    Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunohematological surveillance of the pregnant woman: new prevention policy].
    Mannessier L
    Transfus Clin Biol; 2009 May; 16(2):195-200. PubMed ID: 19419894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhesus disease: the model for fetal therapy.
    Nicolaides KH; Rodeck CH
    Br J Hosp Med; 1985 Sep; 34(3):141-8. PubMed ID: 3933599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory methods for Rh immunoprophylaxis: a review.
    Sandler SG; Sathiyamoorthy S
    Immunohematology; 2010; 26(3):92-103. PubMed ID: 21214295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A; Brossard Y; Beliard R; Bourel D
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immune globulin in the management of severe Rh D hemolytic disease.
    Porter TF; Silver RM; Jackson GM; Branch DW; Scott JR
    Obstet Gynecol Surv; 1997 Mar; 52(3):193-7. PubMed ID: 9061721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

  • 35. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemolytic disease of the newborn: the new NICE guidelines.
    Thompson J
    J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Text of the guidelines for prevention of fetomaternal rhesus-D allo-immunization].
    College National de Gynecolegues et Obstetriciens Francais
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S131-1S135. PubMed ID: 16495839
    [No Abstract]   [Full Text] [Related]  

  • 38. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.
    Mills L; Napier JA
    Br J Obstet Gynaecol; 1988 Oct; 95(10):1007-12. PubMed ID: 2847774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rhesus prophylaxis--history and current status].
    Behrens O; Lellé RJ
    Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists.
    Urbaniak SJ
    Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.